Evaluate the Efficacy and Safety of Topical SHR0302 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis
Clinical trial NCT04717310 · UNKNOWN
Trial details
- NCT number
- NCT04717310
- Sponsor
- Reistone Biopharma Company Limited
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2023-09-08
- Enrollment
- 645
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.